Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Boehringer-Ingelheim
Company Monitoring Page for Boehringer-Ingelheim
latest headlines for company on cafepharma
Eli Lilly, Boehringer Ingelheim's Jardiance clinches heart failure edge with FDA nod for wider label
Fierce Pharma
Fri, 02/25/22 - 10:23 am
Tags:
Eli Lilly
,
Boehringer Ingelheim
,
Jardiance
,
heart failure
,
FDA
Boehringer secures FDA’s Breakthrough Therapy Designation for oral therapy
Pharmaceutical Business Review
Fri, 02/25/22 - 09:58 am
Tags:
Boehringer Ingelheim
,
idiopathic pulmonary fibrosis
,
FDA
,
BI 1015550
,
breakthrough status
Boehringer’s spesolimab data raises hope for serious skin disease
Pharmaforum
Sun, 12/26/21 - 11:14 pm
Tags:
Boehringer Ingelheim
,
spesolimab
,
clinical trials
,
generalized pustular psoriasis
Boehringer invests again in AI diagnosis specialist Brainomix
Pharmaforum
Thu, 12/16/21 - 10:51 am
Tags:
Boehringer Ingelheim
,
Brainomix
,
digital health
,
artificial intelligence
,
Medical Imaging
Boehringer-Lilly’s Jardiance obtains FDA priority review to treat heart failure
Pharmaceutical Business Review
Fri, 11/12/21 - 10:37 am
Tags:
Eli Lilly
,
Boehringer Ingelheim
,
Jardiance
,
priority review
,
FDA
,
heart failure
Boehringer Ingelheim Steps Up to the Plate for Cystic Fibrosis Patients
BioSpace
Tue, 10/19/21 - 10:59 pm
Tags:
Boehringer Ingelheim
,
cystic fibrosis
,
BI 3720931
,
Oxford BioMedica
Boehringer's interchangeable tag for Humira biosim is a 'landmark' win for the field: analyst
Fierce Pharma
Tue, 10/19/21 - 11:59 am
Tags:
Boehringer Ingelheim
,
Humira
,
biosimilars
,
interchangeable biosimilars
,
Cyltezo
,
AbbVie
,
patents
Boehringer wins 'interchangeable' status for Humira copy, strengthening competitive threat
BioPharma Dive
Mon, 10/18/21 - 10:55 pm
Tags:
Boehringer Ingelheim
,
AbbVie
,
Humira
,
interchangeable biosimilars
,
biosimilars
,
Cyltezo
,
FDA
Boehringer Ingelheim inaugurates Vienna production facility
Biopharma Reporter
Thu, 10/14/21 - 11:14 pm
Tags:
Boehringer Ingelheim
,
Austria
,
drug manufactruing
Eli Lilly, Boehringer roll out video game for doctors to highlight cardio-renal-metabolic disease connections
Fierce Pharma
Tue, 10/12/21 - 11:41 pm
Tags:
Eli Lilly
,
Boehringer Ingelheim
,
Jardiance
,
diabetes
,
gamification
Boehringer Ingelheim inaugurates Vienna production facility
Biopharma Reporter
Mon, 10/11/21 - 10:10 am
Tags:
Boehringer Ingelheim
,
Austria
,
drug manufacturing
Sanofi, GSK, Pfizer and Boehringer must face Zantac class-action lawsuits, court rules
Fierce Pharma
Fri, 10/8/21 - 11:00 am
Tags:
GSK
,
Sanofi
,
Pfizer
,
Boehringer Ingelheim
,
legal
,
class action lawsuits
,
Zantac
Boehringer Ingelheim acquires Abexxa Biologics
Biopharma Reporter
Tue, 09/21/21 - 10:56 am
Tags:
Boehringer Ingelheim
,
M&A
,
Abexxa Biologics
,
cancer
,
antibodies
,
drug development
ESMO Preview: Highlights to Watch for This Year
BioSpace
Wed, 09/15/21 - 10:29 pm
Tags:
ESMO
,
oncology
,
cancer
,
Gilead Sciences
,
Bristol Myers Squibb
,
Zymeworks
,
Amgen
,
Adaptimmune Therapeutics
,
TCR2 Therapeutics
,
Boehringer Ingelheim
Boehringer Ingelheim, Twist Bioscience team up for $710M+ antibody discovery collab
Fierce Biotech
Fri, 09/10/21 - 11:10 am
Tags:
drug development
,
Boehringer Ingelheim
,
Twist Bioscience
,
antibody discovery
Could CureVac's Canceled Deal Spell Trouble for Other mRNA Cancer Vaccines?
Motley Fool
Fri, 08/27/21 - 10:54 am
Tags:
CureVac
,
Boehringer Ingelheim
,
MRNA
,
lung cancer
,
vaccines
,
Moderna Therapeutics
,
BioNTech
FDA Approvals Roundup: Korsuva, Jardiance, Xarelto
RAPS.org
Fri, 08/27/21 - 10:36 am
Tags:
Cara Therapeutics
,
Korsuva
,
Boehringer Ingelheim
,
Jardiance
,
Bristol Myers Squibb
,
Opdivo
Jardiance gets parity with Farxiga in US as FDA clears use in heart failure
Pharmaforum
Wed, 08/18/21 - 11:43 pm
Tags:
Eli Lilly
,
Boehringer Ingelheim
,
FDA
,
diabetes
,
Jardiance
,
heart failure with reduced ejection fraction
The 7-year itch? Boehringer culls $600M cancer pact with CureVac, heaping more woe to the biotech
Fierce Biotech
Mon, 08/16/21 - 12:07 pm
Tags:
CureVac
,
MRNA
,
Boehringer Ingelheim
,
COVID-19
,
vaccines
Boehringer takes alteplase to phase 3 for COVID, but drops antibody
Pharmaforum
Tue, 07/27/21 - 10:26 am
Tags:
Boehringer Ingelheim
,
COVID-19
,
antibodies
,
alteplase
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.